• Vaccinex to Present Novel Glial Biomarker Data for Pepinemab at AAIC 2026, Outlining Path to Phase 2b in Alzheimer's Disease BioPharm International Wed, 08 Jul 2026 18:47:54 GMT
• Vaccinex to Present New Biomarker Data From SIGNAL-AD Study Supporting Expanded Phase 2b Trial of Pepinemab in Early Alzheimer’s D... Quiver Quantitative Wed, 08 Jul 2026 12:43:00 GMT
• Vaccinex to show new Alzheimer’s biomarker data in London Stock Titan Wed, 08 Jul 2026 12:32:54 GMT
• Vaccinex to Report New Biomarker Data and Plans for Phase GlobeNewswire Wed, 08 Jul 2026 12:30:00 GMT
• enterprise value to revenue forward of vaccinex, inc. – otc:vcnx TradingView Thu, 25 Jun 2026 19:29:55 GMT
• vaccinex inc stock (us91831v1026): biotech small cap focuses on neurology and oncology after recent Ad-hoc-news.de Mon, 08 Jun 2026 12:02:17 GMT
• vaccinex inc (vcnx) stock forecast, price targets and analysts predictions GuruFocus Thu, 14 May 2026 21:35:34 GMT
• vaccinex inc stock (us91831v1026): biotech innovator in neuroscience AD HOC NEWS Thu, 14 May 2026 14:58:30 GMT
• vaccinex, inc. reports financial results for year ended december 31, 2025 Quiver Quantitative Thu, 30 Apr 2026 07:00:00 GMT
• vaccinex posts 2025 financial statements for clinical-stage biotech Stock Titan Thu, 30 Apr 2026 00:14:51 GMT
• northwestern energy reports first quarter 2026 financial results Weekly Voice Thu, 30 Apr 2026 00:10:34 GMT
• vaccinex, inc. reports financial results for year ended december 31, 2025 Moomoo Wed, 29 Apr 2026 07:00:00 GMT
• vaccinex posts 2025 financial statements for clinical-stage biotech Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• vaccinex inc stock (us91831v1026): is its immunotherapy pipeline strong enough to unlock biotech ups AD HOC NEWS Mon, 20 Apr 2026 02:49:25 GMT
• qualigen therapeutics (nasdaq:aixc) vs. vaccinex (nasdaq:vcnx) financial contrast Defense World Mon, 16 Mar 2026 05:13:03 GMT
• vcnx financials: income statement, balance sheet & cash flow Stock Titan Wed, 04 Mar 2026 13:11:06 GMT
• vcnx financials: income statement, balance sheet & cash flow Stock Titan Wed, 25 Feb 2026 13:28:46 GMT
• vaccinex (vcnx) stock forecast & price prediction 2026–2030 CoinCodex Wed, 18 Feb 2026 03:04:00 GMT
• dub inhibitors market to witness strong expansion across 7mm by 2040 driven by the launch of novel therapeutics | delveinsight PR Newswire Wed, 28 Jan 2026 08:00:00 GMT
• vaccinex (vcnx) stock: micro-cap volatility meets biotech ambition after a steep slide AD HOC NEWS Mon, 19 Jan 2026 08:00:00 GMT
• vaccinex inc (vcnx) is going wild: tiny biotech, massive risk – is it worth the hype? AD HOC NEWS Mon, 19 Jan 2026 08:00:00 GMT
• fda again rejects outlook’s wet amd drug; chinese sirna biotech expects $188m ipo Endpoints News Fri, 02 Jan 2026 08:00:00 GMT
• chinese sirna biotech expects $188m ipo; inflarx seeks gohibic revival in rare skin condition Endpoints News Wed, 31 Dec 2025 08:00:00 GMT
• chinese sirna biotech expects $188m ipo; inflarx seeks gohibic revival in rare skin condition Endpoints News Mon, 29 Dec 2025 17:42:00 GMT
• inflarx seeks gohibic revival in rare skin condition; ask pharm makes china rights deal Endpoints News Mon, 29 Dec 2025 17:42:00 GMT
• ask pharm makes china rights deal; unicycive resubmits kidney drug after crl Endpoints News Mon, 29 Dec 2025 17:42:00 GMT
• fda again rejects outlook’s wet amd drug; chinese sirna biotech expects $188m ipo Endpoints News Mon, 29 Dec 2025 08:00:00 GMT
• head to head contrast: evofem biosciences (nasdaq:evfm) versus vaccinex (nasdaq:vcnx) Defense World Thu, 25 Dec 2025 06:49:23 GMT
• the price of persuasion: why vaccine messaging may deepen social divides EurekAlert! Thu, 25 Dec 2025 06:00:00 GMT
• micro cap biotech secures $60m to advance alzheimer’s treatment, shares surge The Globe and Mail Wed, 24 Dec 2025 11:20:47 GMT
• the price of persuasion: why vaccine messaging may deepen social divides EurekAlert! Wed, 24 Dec 2025 08:00:00 GMT
• vaccinex secures $60 million funding for alzheimer’s drug development by investing.com Investing.com Nigeria Wed, 24 Dec 2025 02:23:47 GMT
• outpace wins 144+ seo awards, establishing itself as one of the best seo agencies in the us The Manila Times Tue, 23 Dec 2025 13:07:43 GMT
• getty realty corp. to report fourth quarter 2025 financial results The Manila Times Tue, 23 Dec 2025 13:07:17 GMT
• aspocomp group plc: notification of management’s transaction - terhi launis (acquisition) The Manila Times Tue, 23 Dec 2025 13:06:42 GMT
• Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease Yahoo Finance Tue, 23 Dec 2025 08:00:00 GMT
• Windtree offloads cardio pipeline, Vaccinex secures $60M funding in continued holiday shopping spree Fierce Biotech Tue, 23 Dec 2025 08:00:00 GMT
• vaccinex, inc. engages in $60 million revenue sharing agreement with pepinemab development venture to advance alzheimer’s treatmen... Quiver Quantitative Tue, 23 Dec 2025 08:00:00 GMT
• new alzheimer’s antibody trial gets $60m boost in search for treatment Stock Titan Tue, 23 Dec 2025 08:00:00 GMT
• vaccinex secures $60 mln to advance enlarged phase 2b alzheimer's trial Nasdaq Tue, 23 Dec 2025 08:00:00 GMT
• vaccinex secures $60 million funding for alzheimer’s drug development Investing.com Tue, 23 Dec 2025 08:00:00 GMT
• vaccinex, inc. enters into a $60 million revenue sharing agreement with pepinemab development venture, lp marketscreener.com Tue, 23 Dec 2025 08:00:00 GMT
• analyzing whitehawk therapeutics (nasdaq:whwk) & vaccinex (nasdaq:vcnx) Defense World Sun, 21 Dec 2025 08:11:45 GMT
• vaccinex (nasdaq:vcnx) trading 4.2% higher – time to buy? Defense World Thu, 13 Nov 2025 21:50:21 GMT
• vaccinex (nasdaq:vcnx) stock price down 5.7% – time to sell? Defense World Wed, 22 Oct 2025 06:40:59 GMT
• huntington’s disease market to evolve rapidly over the next decade by 2034, delveinsight observes | prilenia therapeutics, neurocr... The Globe and Mail Wed, 15 Oct 2025 07:00:00 GMT
• contrasting vaccinex (nasdaq:vcnx) & palatin technologies (pink:ptnt) Defense World Mon, 13 Oct 2025 06:24:04 GMT
• tr | openai - 4o maintains vaccinex(vcnx.us) with hold rating, maintains target price $1 富途牛牛 Sun, 05 Oct 2025 02:52:31 GMT
• vaccinex, inc. (nasdaq:vcnx) sees significant growth in short interest Defense World Mon, 08 Sep 2025 07:00:00 GMT
• GLP-1 Agonists Market to Show Impressive Growth at a CAGR of 10.8% During the Forecast Period (2025-2034) | DelveInsight PR Newswire Fri, 05 Sep 2025 07:00:00 GMT
• vaccinex receives delisting notice from nasdaq, shares down over 49% MSN Sun, 31 Aug 2025 00:27:58 GMT
• tr | openai - 4o maintains vaccinex(vcnx.us) with hold rating, cuts target price to $0.5 富途牛牛 Tue, 26 Aug 2025 07:00:00 GMT
• vaccine x: h5n1 highly pathogenic avian influenza vaccination: seroresponse of mexican poultry in the 2022–2024 Avian Flu Diary Mon, 25 Aug 2025 07:00:00 GMT
• tr | openai - 4o maintains vaccinex(vcnx.us) with hold rating, maintains target price $1 富途牛牛 Sun, 24 Aug 2025 07:00:00 GMT
• head to head survey: aerovate therapeutics (nasdaq:avte) vs. vaccinex (nasdaq:vcnx) Defense World Thu, 21 Aug 2025 05:45:07 GMT
• vaccinex (nasdaq:vcnx) trading 26.3% higher – here’s why Defense World Sat, 16 Aug 2025 06:42:44 GMT
• huntington's disease market to expand significantly by 2034, states delveinsight report prilenia therapeutics, neurocrine bioscien... Menafn Thu, 31 Jul 2025 07:06:59 GMT
• huntington’s disease market to expand significantly by 2034, states delveinsight report | prilenia therapeutics, neurocrine biosci... Barchart.com Thu, 31 Jul 2025 07:00:00 GMT
• huntington’s disease market to expand significantly by 2034, states delveinsight report | prilenia therapeutics, neurocrine biosci... Barchart.com Wed, 30 Jul 2025 14:27:00 GMT
• vaccinex (nasdaq:vcnx) shares down 2.7% – time to sell? Defense World Thu, 03 Jul 2025 07:00:00 GMT
• Anti-CCR8 Antibodies Market to Witness Remarkable Growth Trajectory During the Forecast Period (2025-2040) Across 7MM | DelveInsig... PR Newswire Thu, 26 Jun 2025 07:00:00 GMT
• programming immunogenicity of dengue ediii vaccine antigens using engineered outer membrane vesicles (omvs) ScienceDirect.com Tue, 24 Jun 2025 08:43:00 GMT
• vaccinex (nasdaq:vcnx) shares down 2.4% – time to sell? Defense World Wed, 11 Jun 2025 06:50:44 GMT
• vaccinex (vcnx) showcases pepinemab's role in enhancing cancer immunotherapy | vcnx stock news GuruFocus Tue, 27 May 2025 13:16:27 GMT
• vaccinex to reports new clinical results on pepinemab at asco meeting TipRanks Tue, 27 May 2025 07:00:00 GMT
• vaccinex presents promising cancer treatment data at asco by investing.com Investing.com UK Tue, 27 May 2025 07:00:00 GMT
• vaccinex, inc. to present new data on pepinemab's role in enhancing immune responses in head and neck cancer at asco 2025 Nasdaq Tue, 27 May 2025 07:00:00 GMT
• clinical trial success: new drug transforms cold tumors into hot immune centers in head and neck cancer Stock Titan Tue, 27 May 2025 07:00:00 GMT
• seasonal influenza vaccination: overcoming immunosenescence with enhanced vaccines ScienceDirect.com Wed, 21 May 2025 13:33:28 GMT
• seasonal influenza vaccination: overcoming immunosenescence with enhanced vaccines ScienceDirect.com Tue, 20 May 2025 07:00:00 GMT
• vaccinex (nasdaq:vcnx) stock price down 11.3% – here’s what happened Defense World Tue, 20 May 2025 05:55:33 GMT
• abtherx, single cell technology, and vaccinex announce collaboration to tackle challenging antibody drug targets ACCESS Newswire Tue, 13 May 2025 07:00:00 GMT
• vaccinex (nasdaq:vcnx) trading 9.9% higher – still a buy? Defense World Fri, 25 Apr 2025 08:48:44 GMT
• vaccinex says alzheimer's candidate buoyed by additional early-stage data MSN Tue, 22 Apr 2025 01:52:35 GMT
• vaccinex to report new clinical data on pepinemab in enhancing immunotherapy TipRanks Mon, 21 Apr 2025 12:45:00 GMT
• vaccinex (vcnx) presents new findings on pepinemab for cancer tr GuruFocus Mon, 21 Apr 2025 07:00:00 GMT
• vaccinex to report promising new clinical data revealing GlobeNewswire Mon, 21 Apr 2025 07:00:00 GMT
• vaccinex reports pepinemab boosts immune response in cancer Investing.com Mon, 21 Apr 2025 07:00:00 GMT
• vaccinex, inc. announces promising data on pepinemab as neoadjuvant immunotherapy in metastatic melanoma and head and neck cancer ... Nasdaq Mon, 21 Apr 2025 07:00:00 GMT
• breakthrough: cancer drug transforms 'cold' tumors into 'hot' immune centers, extends survival Stock Titan Mon, 21 Apr 2025 07:00:00 GMT
• osteosarcoma market set for groundbreaking expansion by 2032, forecasts delveinsight | aurora biopharma, bioatla, iovance biothera... The Globe and Mail Thu, 03 Apr 2025 18:58:00 GMT
• vaccinex director resigns, no disagreement cited by investing.com Investing.com South Africa Thu, 20 Mar 2025 08:22:01 GMT
• vaccinex director resigns, no disagreement cited by investing.com Investing.com UK Wed, 19 Mar 2025 20:26:00 GMT
• reverse vaccinology-based multi-epitope covid-19 vaccine targeting sars-cov-2 structural and non-structural proteins induces immun... ScienceDirect.com Tue, 18 Mar 2025 08:47:14 GMT
• finance watch: sutro halves workforce, cuts lead adc and ceo moves on Citeline News & Insights Thu, 13 Mar 2025 07:00:00 GMT
• Vaccinex plans Nasdaq exit as Alzheimer market pressure grows Pharmaceutical Technology Mon, 10 Mar 2025 07:00:00 GMT
• vaccinex plans to delist its common stock from the nasdaq stock market GlobeNewswire Sat, 08 Mar 2025 09:04:34 GMT
• can vaccinex survive after nasdaq exit? key details on company's future strategy Stock Titan Fri, 07 Mar 2025 08:00:00 GMT
• vaccinex plans to delist its common stock from the nasdaq stock market GlobeNewswire Fri, 07 Mar 2025 08:00:00 GMT
• huntington’s disease market growth to accelerate in forecast period (2024-2034), delveinsight analyzes | prilenia therapeutics, ne... The Globe and Mail Fri, 21 Feb 2025 08:00:00 GMT
• vaccinex (nasdaq:vcnx) stock price down 3.7% – time to sell? Defense World Thu, 20 Feb 2025 08:00:00 GMT
• a look back at ground transportation stocks’ q3 earnings: heartland express (nasdaq:htld) vs the rest of the pack The Globe and Mail Tue, 18 Feb 2025 08:00:00 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Fri, 14 Feb 2025 18:39:00 GMT
• lung cancer vaccine trials launched: what you need to know about bnt116 MSN Thu, 30 Jan 2025 15:02:58 GMT
• lung cancer vaccine trials launched: what you need to know about bnt116 MSN Tue, 28 Jan 2025 21:09:09 GMT
• vaccinex stock plunges 24% on mixed results for alzheimer's study MSN Tue, 28 Jan 2025 09:43:58 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Fri, 24 Jan 2025 19:44:00 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Fri, 17 Jan 2025 20:37:00 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Fri, 10 Jan 2025 20:48:00 GMT
• vaccinex (nasdaq:vcnx) stock price down 3.4% – what’s next? Defense World Wed, 08 Jan 2025 08:00:00 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Fri, 03 Jan 2025 18:21:00 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Thu, 02 Jan 2025 08:00:00 GMT
• why 2024 was great for stocks—and why 2025 could be even better The Globe and Mail Tue, 31 Dec 2024 08:00:00 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Fri, 27 Dec 2024 19:48:00 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Tue, 24 Dec 2024 17:34:00 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Fri, 20 Dec 2024 20:59:00 GMT
• vaccinex faces delisting from nasdaq, details plans for otc quotation Defense World Thu, 19 Dec 2024 08:00:00 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Thu, 19 Dec 2024 08:00:00 GMT
• vaccinex to be delisted from nasdaq over equity shortfall by investing.com Investing.com South Africa Wed, 18 Dec 2024 11:21:13 GMT
• vaccinex receives delisting notice from nasdaq, shares down over 49% MSN Wed, 18 Dec 2024 08:00:00 GMT
• vaccinex (otc:vcnx) stock quotes, forecast and news summary Benzinga Wed, 18 Dec 2024 00:43:00 GMT
• vaccinex receives delisting notice from nasdaq, shares down over 49% MSN Tue, 17 Dec 2024 14:40:16 GMT
• vaccinex announces receipt of delisting notification from nasdaq GlobeNewswire Tue, 17 Dec 2024 08:00:00 GMT
Vaccinex, Inc(NASDAQ:VCNX) 
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune diso...
Website: http://www.vaccinex.com
Founded: 2001
Full Time Employees: 45
Sector: Healthcare
Industry: Biotechnology